Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination.

Bühler T, Boos N, Leuppi-Taegtmeyer AB, Berger CT.

NPJ Vaccines. 2019 Dec 17;4:52. doi: 10.1038/s41541-019-0152-2. eCollection 2019.

2.

Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation.

Hirsiger JR, Fuchs PS, Häusermann P, Müller-Durovic B, Daikeler T, Recher M, Hirsch HH, Terracciano L, Berger CT.

Open Forum Infect Dis. 2019 Jul 3;6(9):ofz317. doi: 10.1093/ofid/ofz317. eCollection 2019 Sep.

3.

The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.

Ankli B, Berger CT, Haeni N, Kyburz D, Hügle T, So AK, Daikeler T.

Swiss Med Wkly. 2019 Sep 2;149:w20121. doi: 10.4414/smw.2019.20121. eCollection 2019 Aug 26.

4.

[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?

Imfeld S, Aschwanden M, Rottenburger C, Schegk E, Berger CT, Staub D, Daikeler T.

Rheumatology (Oxford). 2020 Apr 1;59(4):772-778. doi: 10.1093/rheumatology/kez362.

PMID:
31436837
5.

Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: 'Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone' by Samson et al.

Berger CT, Daikeler T.

Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2019-215729. doi: 10.1136/annrheumdis-2019-215729. [Epub ahead of print] No abstract available.

PMID:
31142475
6.

Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.

Berger CT, Rebholz-Chaves B, Recher M, Manigold T, Daikeler T.

Ann Rheum Dis. 2019 Jul;78(7):1012-1014. doi: 10.1136/annrheumdis-2018-214704. Epub 2019 Jan 22. No abstract available.

PMID:
30670375
7.

Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study.

Aschwanden M, Schegk E, Imfeld S, Staub D, Rottenburger C, Berger CT, Daikeler T.

Rheumatology (Oxford). 2019 May 1;58(5):792-797. doi: 10.1093/rheumatology/key383.

PMID:
30544199
8.

The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.

Berger CT, Sommer G, Aschwanden M, Staub D, Rottenburger C, Daikeler T.

Swiss Med Wkly. 2018 Aug 22;148:w14661. doi: smw.2018.14661. eCollection 2018 Aug 13. Review.

9.

Nano-scale microfluidics to study 3D chemotaxis at the single cell level.

Frick C, Dettinger P, Renkawitz J, Jauch A, Berger CT, Recher M, Schroeder T, Mehling M.

PLoS One. 2018 Jun 7;13(6):e0198330. doi: 10.1371/journal.pone.0198330. eCollection 2018.

10.

Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination.

Recher M, Hirsiger JR, Bigler MB, Iff M, Lemaître B, Scherer K, Häusermann P, Siegrist CA, Berger CT.

NPJ Vaccines. 2018 May 18;3:17. doi: 10.1038/s41541-018-0059-3. eCollection 2018.

11.

ADCC-Mediated CD56DIM NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection.

Yu WH, Cosgrove C, Berger CT, Cheney PC, Krykbaeva M, Kim AY, Lewis-Ximenez L, Lauer GM, Alter G.

Pathog Immun. 2018;3(1):2-18. doi: 10.20411/pai.v3i1.228. Epub 2018 Feb 19.

12.

Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires.

Miho E, Yermanos A, Weber CR, Berger CT, Reddy ST, Greiff V.

Front Immunol. 2018 Feb 21;9:224. doi: 10.3389/fimmu.2018.00224. eCollection 2018. Review.

13.

[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.

Imfeld S, Rottenburger C, Schegk E, Aschwanden M, Juengling F, Staub D, Recher M, Kyburz D, Berger CT, Daikeler T.

Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):933-940. doi: 10.1093/ehjci/jex259.

PMID:
29126277
14.

Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al.

Bigler MB, Hirsiger JR, Recher M, Mehling M, Daikeler T, Berger CT.

Arthritis Rheumatol. 2018 Feb;70(2):318-320. doi: 10.1002/art.40363. Epub 2017 Dec 20. No abstract available.

15.

Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis.

Berger CT, Recher M, Daikeler T.

Rheumatology (Oxford). 2018 Jan 1;57(1):196-197. doi: 10.1093/rheumatology/kex336. No abstract available.

PMID:
28968856
16.

Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.

Marquardsen FA, Baldin F, Wunderer F, Al-Herz W, Mikhael R, Lefranc G, Baz Z, Rezaee F, Hanna R, Kfir-Erenfeld S, Stepensky P, Meyer B, Jauch A, Bigler MB, Burgener AV, Higgins R, Navarini AA, Church JA, Chou J, Geha R, Notarangelo LD, Hess C, Berger CT, Bloch DB, Recher M.

J Clin Immunol. 2017 Oct;37(7):707-714. doi: 10.1007/s10875-017-0431-5. Epub 2017 Aug 21.

17.

Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout.

Ankli B, Kyburz D, Hirschmann A, Hügle T, Manigold T, Berger CT, Daikeler T.

Scand J Rheumatol. 2018 Mar;47(2):127-130. doi: 10.1080/03009742.2017.1332239. Epub 2017 Aug 16.

PMID:
28812408
18.

Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy.

Bischof A, Manigold T, Barro C, Heijnen I, Berger CT, Derfuss T, Kuhle J, Daikeler T.

Ann Rheum Dis. 2018 Jul;77(7):1093-1094. doi: 10.1136/annrheumdis-2017-212045. Epub 2017 Jul 25. No abstract available.

PMID:
28743789
19.

Factors associated with significant MRI findings in medical walk-in patients with acute headache.

Budweg J, Sprenger T, De Vere-Tyndall A, Hagenkord A, Stippich C, Berger CT.

Swiss Med Wkly. 2016 Dec 8;146:w14349. doi: 10.4414/smw.2016.14349. eCollection 2016.

20.

Low immunoglobulin E flags two distinct types of immune dysregulation.

Elkuch M, Greiff V, Berger CT, Bouchenaki M, Daikeler T, Bircher A, Navarini AA, Heijnen I, Recher M.

Clin Exp Immunol. 2017 Mar;187(3):345-352. doi: 10.1111/cei.12885. Epub 2017 Jan 11.

21.

Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.

Kistner A, Bigler MB, Glatz K, Egli SB, Baldin FS, Marquardsen FA, Mehling M, Rentsch KM, Staub D, Aschwanden M, Recher M, Daikeler T, Berger CT.

Rheumatology (Oxford). 2017 May 1;56(5):829-834. doi: 10.1093/rheumatology/kew469.

PMID:
28064210
22.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O'Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. Epub 2016 Dec 29.

23.

Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations.

Nordmann TM, Juengling FD, Recher M, Berger CT, Kalbermatten D, Wicki A, Paasinen-Sohns A, Cathomas G, Tzankov A, Daikeler T.

Blood. 2017 Feb 16;129(7):879-882. doi: 10.1182/blood-2016-09-740217. Epub 2016 Dec 9.

PMID:
27940476
24.

Factors associated with significant MRI findings in medical walk-in patients with acute headache.

Budweg J, Sprenger T, De Vere-Tyndall A, Hagenkord A, Stippich C, Berger CT.

Swiss Med Wkly. 2016 Dec 5;146:w14349. doi: 10.4414/smw.2016.14349. eCollection 2016 Dec 5. No abstract available.

25.

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.

Navarini AA, Hruz P, Berger CT, Hou TZ, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg Sgier BC, Kämpe O, Burgener AV, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker LT, Heijnen I, Daikeler TD, Gebbers JO, Grimbacher B, Sansom DM, Jeker R, Hess C, Recher M.

J Allergy Clin Immunol. 2017 Mar;139(3):1043-1046.e5. doi: 10.1016/j.jaci.2016.08.042. Epub 2016 Nov 28. No abstract available.

PMID:
27908448
26.

HLA-C levels impact natural killer cell subset distribution and function.

Sips M, Liu Q, Draghi M, Ghebremichael M, Berger CT, Suscovich TJ, Sun Y, Walker BD, Carrington M, Altfeld M, Brouckaert P, De Jager PL, Alter G.

Hum Immunol. 2016 Dec;77(12):1147-1153. doi: 10.1016/j.humimm.2016.08.004. Epub 2016 Aug 10.

27.

Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells.

Berger CT, Hess C.

J Clin Invest. 2016 May 2;126(5):1646-8. doi: 10.1172/JCI87429. Epub 2016 Apr 18.

28.

A 'Too Negative' ANA Test Predicts Antibody Deficiency.

Recher M, Berger CT, Daikeler T, Hess C, Heijnen IA.

J Clin Immunol. 2016 May;36(4):374-6. doi: 10.1007/s10875-016-0262-9. Epub 2016 Mar 10. No abstract available.

PMID:
26961361
29.

Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.

Bigler MB, Egli SB, Hysek CM, Hoenger G, Schmied L, Baldin FS, Marquardsen FA, Recher M, Liechti ME, Hess C, Berger CT.

PLoS One. 2015 Dec 23;10(12):e0145635. doi: 10.1371/journal.pone.0145635. eCollection 2015.

30.

Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study.

Berger CT, Greiff V, John S, Koenig KF, Bigler MB, Recher M, Hess C, Daikeler T.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-122-5. Epub 2015 May 26.

PMID:
26016762
31.

The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.

Aschwanden M, Imfeld S, Staub D, Baldi T, Walker UA, Berger CT, Hess C, Daikeler T.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-113-5. Epub 2015 May 26.

PMID:
26016760
32.

Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.

Berger CT, Greiff V, Mehling M, Fritz S, Meier MA, Hoenger G, Conen A, Recher M, Battegay M, Reddy ST, Hess C.

Hum Vaccin Immunother. 2015;11(2):391-6. doi: 10.1080/21645515.2015.1008930.

33.

Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.

Berger CT, Llano A, Carlson JM, Brumme ZL, Brockman MA, Cedeño S, Harrigan PR, Kaufmann DE, Heckerman D, Meyerhans A, Brander C.

J Virol. 2015 Apr;89(7):4015-9. doi: 10.1128/JVI.03435-14. Epub 2015 Jan 14.

34.

Diagnosis at your fingertips: splinters and microemboli--is it SLE?

Berger CT, Baldi T, Aschwanden M, Scherer K, Recher M, Hess C, Daikeler T.

Lupus. 2015 Mar;24(3):341-2. doi: 10.1177/0961203314558862. Epub 2014 Nov 6. No abstract available.

PMID:
25378240
35.

Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.

Cosgrove C, Berger CT, Kroy DC, Cheney PC, Ghebremichael M, Aneja J, Tomlinson M, Kim AY, Lauer GM, Alter G.

PLoS One. 2014 Aug 22;9(8):e105950. doi: 10.1371/journal.pone.0105950. eCollection 2014.

36.

Incidence and prognostic implications of diplopia in patients with giant cell arteritis.

Haering M, Holbro A, Todorova MG, Aschwanden M, Kesten F, Berger CT, Tyndall A, Benz D, Hess C, Daikeler T.

J Rheumatol. 2014 Jul;41(7):1562-4. doi: 10.3899/jrheum.130983. No abstract available.

PMID:
24986968
37.

[Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].

Balmer ML, Berger CT.

Ther Umsch. 2014 Jan;71(1):5-15. doi: 10.1024/0040-5930/a000476. Review. German.

PMID:
24394204
38.

Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype.

Recher M, Karjalainen-Lindsberg ML, Lindlöf M, Söderlund-Venermo M, Lanzi G, Väisänen E, Kumar A, Sadeghi M, Berger CT, Alitalo T, Anttila P, Kolehmainen M, Franssila R, Chen T, Siitonen S, Delmonte OM, Walter JE, Pessach I, Hess C, Simpson MA, Navarini AA, Giliani S, Hedman K, Seppänen M, Notarangelo LD.

J Allergy Clin Immunol. 2014 May;133(5):1462-5, 1465.e1-5. doi: 10.1016/j.jaci.2013.10.052. Epub 2013 Dec 24. No abstract available.

PMID:
24373355
39.

IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.

Berger CT, Kim AY.

Infect Dis Clin North Am. 2012 Dec;26(4):863-77. doi: 10.1016/j.idc.2012.08.010. Review.

40.

Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells.

Yamanaka YJ, Berger CT, Sips M, Cheney PC, Alter G, Love JC.

Integr Biol (Camb). 2012 Oct;4(10):1175-84.

PMID:
22945136
41.

A 17q12 allele is associated with altered NK cell subsets and function.

Xia Z, Liu Q, Berger CT, Keenan BT, Kaliszewska A, Cheney PC, Srivastava GP, Castillo IW, De Jager PL, Alter G.

J Immunol. 2012 Apr 1;188(7):3315-22. doi: 10.4049/jimmunol.1102775. Epub 2012 Feb 15.

42.

CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.

Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, Plana M, Rolland M, Khatri A, Heckerman D, Pereyra F, Walker BD, Weiner D, Paredes R, Clotet B, Felber BK, Pavlakis GN, Mullins JI, Brander C.

PLoS One. 2012;7(1):e29717. doi: 10.1371/journal.pone.0029717. Epub 2012 Jan 4.

43.

Definition of the viral targets of protective HIV-1-specific T cell responses.

Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreño J, Bach V, Zuniga R, Pérez-Álvarez S, Berger CT, Puertas MC, Martinez-Picado J, Rolland M, Farfan M, Szinger JJ, Hildebrand WH, Yang OO, Sanchez-Merino V, Brumme CJ, Brumme ZL, Heckerman D, Allen TM, Mullins JI, Gómez G, Goulder PJ, Walker BD, Gatell JM, Clotet B, Korber BT, Sanchez J, Brander C.

J Transl Med. 2011 Dec 7;9:208. doi: 10.1186/1479-5876-9-208.

44.

Altered distribution of mucosal NK cells during HIV infection.

Sips M, Sciaranghella G, Diefenbach T, Dugast AS, Berger CT, Liu Q, Kwon D, Ghebremichael M, Estes JD, Carrington M, Martin JN, Deeks SG, Hunt PW, Alter G.

Mucosal Immunol. 2012 Jan;5(1):30-40. doi: 10.1038/mi.2011.40. Epub 2011 Oct 12.

45.

High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, Hartman KL, Henry LM, Brenchley JM, Ruff LE, Venturi V, Pereyra F, Sidney J, Sette A, Douek DC, Walker BD, Kaufmann DE, Brander C.

J Virol. 2011 Sep;85(18):9334-45. doi: 10.1128/JVI.00460-11. Epub 2011 Jul 13.

46.

Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Dugast AS, Tonelli A, Berger CT, Ackerman ME, Sciaranghella G, Liu Q, Sips M, Toth I, Piechocka-Trocha A, Ghebremichael M, Alter G.

Virology. 2011 Jul 5;415(2):160-7. doi: 10.1016/j.virol.2011.03.012. Epub 2011 May 12.

47.

Natural killer cells in spontaneous control of HIV infection.

Berger CT, Alter G.

Curr Opin HIV AIDS. 2011 May;6(3):208-13. doi: 10.1097/COH.0b013e3283457798. Review.

PMID:
21399495
48.

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.

Ackerman ME, Moldt B, Wyatt RT, Dugast AS, McAndrew E, Tsoukas S, Jost S, Berger CT, Sciaranghella G, Liu Q, Irvine DJ, Burton DR, Alter G.

J Immunol Methods. 2011 Mar 7;366(1-2):8-19. doi: 10.1016/j.jim.2010.12.016. Epub 2010 Dec 27. Erratum in: J Immunol Methods. 2012 Feb 28;376(1-2):156.

49.

Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers.

Fink NS, Urech C, Berger CT, Hoesli I, Holzgreve W, Bitzer J, Alder J.

J Matern Fetal Neonatal Med. 2010 Jun;23(6):488-500. doi: 10.3109/14767050903300985.

PMID:
20298130
50.

Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.

Berger CT, Carlson JM, Brumme CJ, Hartman KL, Brumme ZL, Henry LM, Rosato PC, Piechocka-Trocha A, Brockman MA, Harrigan PR, Heckerman D, Kaufmann DE, Brander C.

J Exp Med. 2010 Jan 18;207(1):61-75. doi: 10.1084/jem.20091808. Epub 2010 Jan 11.

Supplemental Content

Loading ...
Support Center